On June 12, 2025, CareDx, Inc. reported that its stockholders approved an amendment to the 2024 Equity Incentive Plan, increasing the number of shares available for grants by 1,600,000 shares, representing around 3% of common shares outstanding. The amendment had been proposed by the Board of Directors on April 23, 2025, and was approved alongside the election of two directors and the selection of Deloitte & Touche LLP as the company's accounting firm for the fiscal year 2025.